Your Challenges Require Smart Solutions:
PharmaLKF - Central LaboratorySafety Analysis

Safety Analysis

A comprehensive clinical laboratory testing programme

LKF offers a comprehensive clinical laboratory testing programme. Whenever possible, the methods and procedures applied are those recommended by international scientific societies, e.g. IFCC, ECAT, or traceable to approved reference material.

Furthermore, LKF has expertise in the development, evaluation and reference interval establishment of new analytical methods. 

Analyses are performed in a timely and accurate manner. Measurements of routine and safety parameters, including reporting of test results, are usually completed on the day of specimen receipt, six days a week.

LKF provides analytical services in the following sub-specialities:

  • Clinical Chemistry
  • Hematology
  • Flow Cytometry
  • Coagulation
  • Endocrinology
  • Immunology
  • Serology
  • Microbiology
  • Molecular Biology
  • PBMC Isolation
  • Pathological Anatomy/Cytology
  • PCR
  • MSD

Although laboratory methods are frequently modified or changed due to technical developments and/or methodological progress, consistency of methodology is provided for the entire period of a trial.

The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.

Solutions

More

Specimen Management

Bioanalytical Services

Proficiency Testing Certificates

Reporting

Quality Assurance

LKF Central Laboratory

Downloads

GBA Group Pharma

Your direct contact

David Ommer
Business Administration, M.Sc.
+49 4307 8276 – 0
project@lkf-kiel.de

Business Development

Contact us!

To learn more about us and what we can do for you please contact David Ommer.

Your contact for pharmaceutical services
Contact form

Your contact for pharmaceutical services

Do you have a questions or concern about a topic and would like to contact us?

Contact form
STAY IN TOUCH

GBA Group Pharma Newsletter

Always stay up to date and register for our newsletter.

© 2020 GBA Group
Data PrivacyLegal NoticeTerms & ConditionsDisclosure